{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-24-000009","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.132712+00:00","generated_at":"2026-06-06T10:32:20.655587+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Quest Diagnostics Q4 2023 adjusted EPS $2.15, +8.6%; base business revenue +4.7%","bullets":["Q4 reported net revenue $2.29B (-1.9% YoY); base business revenue $2.25B (+4.7%).","Q4 reported diluted EPS $1.70 (+95.4%); adjusted diluted EPS $2.15 (+8.6%).","Full year 2023 base business revenue grew 7.1% to $9.03B; COVID testing fell 84.7% to $223M.","Quarterly dividend raised 5.6% to $0.75; payable April 22, 2024 to record date April 8.","FY2024 guidance: revenue $9.35-$9.45B; reported EPS $7.69-$7.99; adjusted EPS $8.60-$8.90."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-24-000009","json":"https://secwatch.observer/filing/0001022079-24-000009.json","markdown":"https://secwatch.observer/filing/0001022079-24-000009.md","text":"https://secwatch.observer/filing/0001022079-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000009/0001022079-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000009/dgx-20240201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T10:32:20.655587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7a6911da656b1565be52d599864acd14f094bdda","claim":"QUEST DIAGNOSTICS INC reported quarter and full year ended December 31, 2023 results: revenue Fourth quarter revenues of $2.29 billion, EPS Fourth quarter reported diluted earnings per share (\"EPS\") of $1.70. Guidance initiated.","evidence_excerpt":"Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share • Fourth quarter revenues of $2.29 billion, down 1.9% from 2022 • Fourth quarter reported diluted earnings per share (\"EPS\") of $1.70, up 95.4% from 2022; and adjusted diluted EPS of $2.15, up 8.6% from 2022 • Fourth","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000009/0001022079-24-000009-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"Fourth quarter revenues of $2.29 billion"},{"label":"EPS","value":"Fourth quarter reported diluted earnings per share (\"EPS\") of $1.70"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}